Austin Marsh

Morrison & Foerster LLP

+ Follow Contact

Readers' Choice Awards

Product Liability

Latest Posts › Birth Defects

Share:

Another Step Toward Reasonable Preemption Case Law

Last month, the Sixth Circuit affirmed a complete defense verdict for Abbott Laboratories Inc. which was based in part on branded drug preemption. Rheinfrank v. Abbott Laboratories Inc., Case No. 16-3347, 2017 WL 680349 (6th...more

4/6/2017 / Abbott Laboratories , Birth Defects , Black Box Warnings , Food and Drug Administration (FDA) , Manufacturers , Preemption

Federal Preemption Claims: Clear Evidence and an Unclear Standard

Last week, a federal court in Utah granted Aventis Inc.’s motion for summary judgment based on federal preemption of failure-to-warn claims. Cerveny v. Aventis, Inc., 2016 U.S. Dist. LEXIS 34182 (D. Utah Mar. 16, 2016). The...more

4/1/2016 / Birth Defects , Failure To Warn , Food and Drug Administration (FDA) , Labeling , Pharmaceutical Industry , Preemption , Prescription Drugs , Summary Judgment

2 Results

View per page

Page: of 1